Truthful Prescription Drug Advertising and Promotion--This is What I posted about yesterday--Look At What A Great Job FDA is doing on getting the message out and education the public

Truthful Prescription Drug Advertising and Promotion

 

FDA's Bad Ad program is an outreach program designed to educate healthcare providers about the role they can play in helping the agency make sure that prescription drug advertising and promotion is truthful and not misleading.  The Bad Ad Program is administered by the agency’s Office of Prescription Drug Promotion (OPDP) in the Center for Drug Evaluation and Research. The program's goal is to help raise awareness among healthcare providers about misleading prescription drug promotion and provide them with an easy way to report this activity to the agency: e-mail BadAd@fda.gov or call 855-RX-BADAD. Bad Ad CME/CE course and Educational Case Studies:  As part of FDA's Bad Ad program, OPDP introduces a new CME/CE e-learning course and case studies to raise healthcare providers (HCP) and HCP students' awareness of misleading prescription drug promotion and other common regulatory concerns. Please click on the buttons to the right to access these resources.  Content on this Page Bad Ad Program: 2011-2012 Year End Report Bad Ad Program: 2010-2011 Year End Report Examples of Violations Frequently Asked Questions Report: Contact Information The OPDP Mission
	View Brochure (PDF- 400KB)